INTEGRA LIFESCIENCES HOLDINGS CORP (IART) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$13.13

From 52W high−32.24%

Volume726139.00

Market cap$1.05B

P/E (TTM)—

P/S (TTM)0.6x

Div yield—

Key dataOct 19, 2026

Open

$13.13

From 52W high

−32.24%

Volume

726139.00

Market cap

$1.05B

ValuationView details →

P/E (Fwd)

5.3x

EV/EBITDA

11.3x

P/E (TTM)

—

RSI (14)

39.3

MomentumView details →

1D Return

+1.82%

YTD Return

+7.93%

SummaryUpdated Jun 1, 2026

Integra LifeSciences Holdings Corporation (NASDAQ:IART) is a medical device company founded in 1989 and headquartered in Princeton, New Jersey. The company went public in 1995 and has grown through both organic expansion and strategic acquisitions to become a significant player in the neurosurgery, wound care, and surgical reconstruction markets. Integra operates through two main business segments and serves hospitals, surgery centers, and healthcare providers globally with a portfolio of surgical implants, medical instruments, and regenerative tissue products.

Ask drillr about INTEGRA LIFESCIENCES HOLDINGS CORP →

ValuationView details →

P/E (Fwd)

5.3x

P/E (TTM)

—

EV/EBITDA

11.3x

EV/Sales

1.7x

P/S (TTM)

0.6x

P/B (TTM)

1.0x

ProfitabilityView details →

Gross Margin

53.74%

Net Margin

−0.44%

EBITDA Margin

15.15%

ROE (TTM)

−0.69%

ROA (TTM)

−0.20%

Asset Turnover

0.46x

GrowthView details →

Revenue YoY

+1.60%

EPS YoY

+98.59%

FCF YoY

+181.80%

Revenue CAGR 3Y

+1.63%

EPS CAGR 3Y

—

EBITDA YoY

+175.14%

MomentumView details →

1D Return

+1.82%

YTD Return

+7.93%

1Y Return

−14.56%

RSI (14)

39.3

vs 50D SMA

−14.92%

vs 200D SMA

−4.86%

Capital & dividendView details →

Debt/Equity

1.94x

Current Ratio

3.40x

Quick Ratio

1.98x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

$0.56

EPS Surprise

16.55%

Beats (12Q)

10/12

Next Q EPS Est

$0.74

Avg Surprise (4Q)

19.72%

Rev Surprise

0.29%

Financials snapshotView financials →

Revenue (TTM)

1.65B

Net Income (TTM)

−7.24M

Op. CF (TTM)

85.33M

Next earningsOct 21, 2026 →

Latest newsMore news →

INTEGRA LIFESCIENCES HOLDINGS CORP closed a private offering of $450.0 million in aggregate principal amount of 9.500% senior secured notes due 2033.4h ago

Johnson Fistel, PLLP announced it is investigating Integra LifeSciences Holdings Corporation on behalf of investors who may have suffered losses following flooding-related outlook cuts and a 21% stock decline.15d ago

Similar companies

PROCEPT BioRobotics CorporationPRCT Artivion, Inc.AORT CeriBell, Inc.CBLL IRadimed CorporationIRMD Tandem Diabetes Care, Inc.TNDM Avanos Medical, Inc.AVNS Find similar companies →

Latest newsMore news →

INTEGRA LIFESCIENCES HOLDINGS CORP closed a private offering of $450.0 million in aggregate principal amount of 9.500% senior secured notes due 2033.4h ago Johnson Fistel, PLLP announced it is investigating Integra LifeSciences Holdings Corporation on behalf of investors who may have suffered losses following flooding-related outlook cuts and a 21% stock decline.15d ago SueWallSt notified investors of a pending investigation into potential securities claims against Integra LifeSciences on behalf of shareholders who lost money after the company's preliminary third-quarter revenue fell $4.3 million to $6.3 million short of Wall Street estimates.17d ago